Viewing data from:

DEXRAZOXANE HYDROCHLORIDE

ANDA

DEXRAZOXANE HYDROCHLORIDE | A207321 | GLAND PHARMA LTD

2 strengths0 unique patents0 unique exclusivities

API Supply Chain7 active DMFs1 inactive

6 active API suppliers hold Drug Master Files for this ingredient.

STERLING WISCONSIN LLCDEXRAZOXANE (FP-048)

DMF 183362005

TAPI NL BVDEXRAZOXANE (ICRF-187)

DMF 190022005

GLAND PHARMA LTDDEXRAZOXANE

DMF 231722009

GLAND PHARMA LTDDEXRAZOXANE (PROCESS-II)

DMF 278262014

MSN LABORATORIES PRIVATE LTDDEXRAZOXANE

DMF 346942020

APITORIA PHARMA PRIVATE LTDDEXRAZOXANE

DMF 377162022

PORTON PHARMA SOLUTIONS LTDDEXRAZOXANE

DMF 381862023

BOEHRINGER INGELHEIM CHEMICALS INCInactiveDEXRAZOXANE

DMF 151842000

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 500MG BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Nov 28, 2016

No patent or exclusivity listings for this strength.

#002 — EQ 250MG BASE/VIAL

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Dec 16, 2019